Login / Signup

Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use.

Yong-Bum ParkToby M MaherTamera J CorteMaria Molina-MolinaJudit AxmannFrank GilbergKlaus-Uwe KirchgaesslerVincent Cottin
Published in: Advances in therapy (2021)
ClinicalTrials.gov: NCT03099187.
Keyphrases
  • interstitial lung disease
  • idiopathic pulmonary fibrosis
  • systemic sclerosis
  • rheumatoid arthritis
  • randomized controlled trial
  • phase iii